Ledger.Open graph →
SEC Form D · Amendment · filed March 8, 2017

Romark Global Pharma, LLC

Offering
$50.0M
Sold
$13.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
GUAYNABO, Puerto Rico
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

W. S. Holt · Tampa, FLDirectorJean-Francois Rossignol, M.D., Ph.D · Tampa, FLExec · Director · PromoterMarc S. Ayers · Tampa, FLExec · Director · PromoterW. A. Krusen Jr · Tampa, FLDirectorCeline S. Rossignol · Tampa, FLExecRobert Alumbaugh · Riverside, MOExecWei Zhou · Grand Cayman, Cayman IslandsExec · Director · PromoterDavid Eisner · New York, NYExec · Director · PromoterMitchel Kraskin · New York, NYDirectorWayne S. Burks · Tampa, FLExecBenjamin Jen · Grand Cayman, Cayman IslandsExec · DirectorAmy G. Shenkan · PHILADELPHIA, PAExec · Director · PromoterJulie J. Roehm · PHILADELPHIA, PADirectorJason N. Gorevic · PURCHASE, NYDirectorAdam C. Vandervoort · PURCHASE, NYExec · Director · PromoterWayne S. Burks · Tampa, FLExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗